Manual literature synthesis for human ITIH3 (Q06033) Manual

Manual literature synthesis for human ITIH3 (Q06033)

Automated deep-research providers were attempted on 2026-07-18 but were unavailable (Falcon/Edison HTTP 402; Perplexity-lite HTTP 401). This manual synthesis is based on the reviewed UniProtKB record, cached primary publications, and the current Reactome record.

Biological synthesis

ITIH3 encodes HC3, a secreted heavy-chain component of human pre-alpha-inhibitor. Its precursor is processed to a mature chain whose C-terminal Asp651 is ester-linked through chondroitin 4-sulfate to bikunin. Human biochemical studies establish that pre-alpha-inhibitor contains one 90-kDa heavy chain and one 30-kDa inhibitory chain [PMID:2476436, "each protein contained a single, identical, trypsin-inhibitory chain of 30,000 Da"]. A later purification study identifies that inhibitory component explicitly: pre-alpha-inhibitor "comprises bikunin (BK) responsible for antiprotease activity, covalently linked to a heavy chain H3" PMID:9188816. Thus HC3 is not itself an endopeptidase inhibitor.

HC3's defining function is participation in the hyaluronan-rich extracellular matrix. A direct study of purified human HC3 identified an N-terminal BX7B HA-binding sequence. The binding activity was cryptic in the intact mature chain but became strong after thermolysin generated an N-terminal fragment [PMID:11168393, "unmasking this HA-binding activity required most of H3P to be trimmed off at its C-terminal end"]. More decisively, reconstitution with purified human plasma components showed that HC2-containing proteins promote formation of covalent HC3-TSG-6 and then HC3-hyaluronan complexes [PMID:18448433, "both HC2 and TSG-6 are required for the transesterification reactions to occur"]. HC3 is therefore a transferable HA-associated heavy chain, while TSG-6 and HC2 supply the transfer mechanism.

Mouse studies independently found HC3 in physiological and pathological SHAP-hyaluronan complexes and in complexes formed in vitro [PMID:18293178, "All three HC isoforms are found in the SHAP-hyaluronan complexes of physiological or pathological origins as well as that formed in vitro"]. This ortholog evidence supports extracellular-matrix localization for human HC3, while the direct purified-human experiment establishes the biochemical capacity to form HC3-HA. No human disease or reproductive process was assigned because the available studies do not isolate an ITIH3-specific causal role in those processes.

Core conclusion

The core function of ITIH3 is to provide the noninhibitory HC3 component of plasma pre-alpha-inhibitor and, following HC2- and TSG-6-dependent transesterification, an HA-associated heavy chain incorporated into HA-rich extracellular matrices. Hyaluronic acid binding is supported for a proteolytically exposed HC3 fragment and by HC3-HA complex formation; hyaluronan metabolic process, extracellular matrix, and extracellular space are the most defensible accompanying GO concepts. Protease inhibition belongs to bikunin, not ITIH3.

Evidence limitations

The direct HC3 binding, HC3 transfer, pre-alpha-inhibitor purification, chain-crosslink, and mouse SHAP-HA papers are available only as abstracts in the local cache. Their abstracts explicitly support the conclusions above but do not establish tissue-specific kinetics or disease causality. The platelet dense-granule annotation is target-specific in Reactome's current participant set, but its underlying PMID:1435334 record contains no accessible abstract or ITIH3-specific text. Exosome recovery is retained as non-core because the source is a proteomic preparation of a secreted-body-fluid fraction.